Hegde Akhil, Strachan Ryan T, Walker Julia K L
Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Howard Hughes Medical Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
PLoS One. 2015 Feb 6;10(2):e0116458. doi: 10.1371/journal.pone.0116458. eCollection 2015.
In allergic asthma Beta 2 adrenergic receptors (β2ARs) are important mediators of bronchorelaxation and, paradoxically, asthma development. This contradiction is likely due to the activation of dual signaling pathways that are downstream of G proteins or β-arrestins. Our group has recently shown that β-arrestin-2 acts in its classical role to desensitize and constrain β2AR-induced relaxation of both human and murine airway smooth muscle. To assess the role of β-arrestins in regulating β2AR function in asthma, we and others have utilized β-arrestin-1 and -2 knockout mice. However, it is unknown if genetic deletion of β-arrestins in these mice influences β2AR expression in the airways. Furthermore, there is lack of data on compensatory expression of βAR subtypes when either of the β-arrestins is genetically deleted, thus necessitating a detailed βAR subtype expression study in these β-arrestin knockout mice. Here we standardized a radioligand binding methodology to characterize and quantitate βAR subtype distribution in the airway smooth muscle of wild-type C57BL/6J and β-arrestin-1 and β-arrestin-2 knockout mice. Using complementary competition and single-point saturation binding assays we found that β2ARs predominate over β1ARs in the whole lung and epithelium-denuded tracheobronchial smooth muscle of C57BL/6J mice. Quantification of βAR subtypes in β-arrestin-1 and β-arrestin-2 knockout mouse lung and epithelium-denuded tracheobronchial tissue showed that, similar to the C57BL/6J mice, both knockouts display a predominance of β2AR expression. These data provide further evidence that β2ARs are expressed in greater abundance than β1ARs in the tracheobronchial smooth muscle and that loss of either β-arrestin does not significantly affect the expression or relative proportions of βAR subtypes. As β-arrestins are known to modulate β2AR function, our analysis of βAR subtype expression in β-arrestin knockout mice airways sets a reference point for future studies exploiting these knockout mice in various disease models including asthma.
在过敏性哮喘中,β2肾上腺素能受体(β2ARs)是支气管舒张的重要介质,而矛盾的是,它也参与哮喘的发展。这种矛盾可能是由于G蛋白或β-抑制蛋白下游的双重信号通路被激活所致。我们团队最近发现,β-抑制蛋白-2发挥其经典作用,使人和小鼠气道平滑肌中β2AR诱导的舒张反应脱敏并受到抑制。为了评估β-抑制蛋白在哮喘中调节β2AR功能的作用,我们和其他研究人员使用了β-抑制蛋白-1和-2基因敲除小鼠。然而,尚不清楚这些小鼠中β-抑制蛋白的基因缺失是否会影响气道中β2AR的表达。此外,当任一β-抑制蛋白被基因敲除时,缺乏关于βAR亚型代偿性表达的数据,因此有必要在这些β-抑制蛋白基因敲除小鼠中进行详细的βAR亚型表达研究。在此,我们标准化了一种放射性配体结合方法,以表征和定量野生型C57BL/6J小鼠以及β-抑制蛋白-1和β-抑制蛋白-2基因敲除小鼠气道平滑肌中βAR亚型的分布。通过互补竞争和单点饱和结合试验,我们发现,在C57BL/6J小鼠的全肺以及去上皮的气管支气管平滑肌中,β2ARs的表达量超过β1ARs。对β-抑制蛋白-1和β-抑制蛋白-2基因敲除小鼠肺组织以及去上皮的气管支气管组织中的βAR亚型进行定量分析表明,与C57BL/6J小鼠相似,两种基因敲除小鼠均表现出β2AR表达占优势。这些数据进一步证明,在气管支气管平滑肌中,β2ARs的表达量高于β1ARs,并且任一β-抑制蛋白的缺失均不会显著影响βAR亚型的表达或相对比例。由于已知β-抑制蛋白可调节β2AR功能,我们对β-抑制蛋白基因敲除小鼠气道中βAR亚型表达的分析为未来在包括哮喘在内的各种疾病模型中利用这些基因敲除小鼠的研究设定了一个参考点。